Biomarkers of Diabetes

Biomarkers are molecular markers used as direct or indirect markers of the extent of a disease. HbA1c is considered as the biomarker in diabetes for assessing the risk factor related to retinopathy, nephropathy and other vascular diseases. Biomarkers enable preventive measures to be applied at the subclinical stage and the responses to preventive or therapeutic measures to be monitored.

  • Novel Biomarkers
  • Advances in Molecular Diagnostics
  • HbA1c Biomarker

Related Conference of Biomarkers of Diabetes

March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
May 14-15, 2026

7th World Summit on Diabetes

Rome, Italy
May 18-19, 2026

57th Annual Congress on Endocrinology and Diabetes Research

Aix-en-Provence, France
June 22-23, 2026

16th World Congress on Endocrinology and Diabetes

Paris, France
August 17-18, 2026

4th World congress and Expo on Diabetes

Toronto, Canada
September 29-30, 2026

22nd World Congress on Endocrinology & Diabetes

Paris, France

Biomarkers of Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in